Attovia Therapeutics price target set at $45.00 by LifeSci Capital
LifeSci Capital announced a $45.00 per share price target for Attovia Therapeutics.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.